N-bromobutanimide → [2-(1-benzyl-3-bromo-1H-indol-4-yloxy)-ethyl]-methyl-carbamic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6](=[O:29])[N:7]([CH2:9][CH2:10][O:11][C:12]1[CH:20]=[CH:19][CH:18]=[C:17]2[C:13]=1[CH:14]=[CH:15][N:16]2[CH2:21][C:22]1[CH:27]=[CH:26][CH:25]=[C:24](F)[CH:23]=1)[CH3:8])([CH3:4])([CH3:3])[CH3:2].[Br:30]N1C(=O)CCC1=O>>[C:1]([O:5][C:6](=[O:29])[N:7]([CH2:9][CH2:10][O:11][C:12]1[CH:20]=[CH:19][CH:18]=[C:17]2[C:13]=1[C:14]([Br:30])=[CH:15][N:16]2[CH2:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1)[CH3:8])([CH3:4])([CH3:3])[CH3:2]Participants
3
Procedure
{2-[1-(3-Fluoro-benzyl)-1H-indol-4-yloxy]-ethyl}-methyl-carbamic acid tert-butyl ester was treated with N-bromosuccinimide using the procedure of step 3 of Example 6 to provide [2-(1-benzyl-3-bromo-1H-indol-4-yloxy)-ethyl]-methyl-carbamic acid tert-butyl ester.
Sources & evidence
- ORD record
- ord-0ea311cbf6b242d8b1ee07199df9a540
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07582760B2
Reaction notes
Loading…